Whether people with HIV had hepatitis or not didn't change the relationship between losing belly fat and improving liver enzymes.

Whether HIV patients had hepatitis or not didn't change the benefit of visceral fat loss on liver enzymes when taking tesamorelin.

Whether HIV patients had hepatitis or not didn't change the link between losing visceral fat and improving liver enzyme levels.

Whether HIV patients had hepatitis or not didn't change the link between losing visceral fat and improving liver enzymes.

For HIV patients with belly fat and high liver enzymes, losing visceral fat improved liver enzymes whether they had hepatitis or not.

In people with HIV and belly fat, the amount of visceral fat didn't correlate with liver enzyme AST levels when other factors like sex and hepatitis were considered.